Dark

Check out our API

AIMT
Aimmune Therapeutics, Inc. Common Stock
stock NASDAQ

Inactive

Oct 12, 2020

34.49USD-0.289%(-0.10)987,254

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsTrends

AIMT Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

AIMT Specific Mentions

As of Jul 13, 2025 1:12:57 PM EDT (<1 min. ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

53 days ago • u/Financial-Stick-8500 • r/Biotechplays • deadline_for_getting_payment_on_aimmune • News • B

If you missed it, Aimmune (now part of Nestle) agreed to settle with investors over hiding key info in the process of its merger with Nestlé. And the filing deadline is in two weeks.
Quick recap: In 2020, Aimmune Therapeutics announced a merger with Nestlé, assuring investors it was a fair deal. However, the Recommendation Statement left out key financial details, raising concerns.
Soon, Aimmune faced a lawsuit from investors because the Statement left out cash flow estimates, key assumptions about future profits, and the calculations used to assess the deal’s value.
Now, Aimmune agreed to settle and pay $27.5M to investors to resolve this situation. And the filing deadline is in two weeks from now. So if you got hit back then, you can [check the details and file](https://11th.com/cases/aimmune-investor-settlement) for payment.
Anyways, did anyone here get damaged by $AIMT back then? How much were your losses if so?

53 days ago • u/Financial-Stick-8500 • r/Biotechplays • deadline_for_getting_payment_on_aimmune • News • B

If you missed it, Aimmune (now part of Nestle) agreed to settle with investors over hiding key info in the process of its merger with Nestlé. And the filing deadline is in two weeks.
Quick recap: In 2020, Aimmune Therapeutics announced a merger with Nestlé, assuring investors it was a fair deal. However, the Recommendation Statement left out key financial details, raising concerns.
Soon, Aimmune faced a lawsuit from investors because the Statement left out cash flow estimates, key assumptions about future profits, and the calculations used to assess the deal’s value.
Now, Aimmune agreed to settle and pay $27.5M to investors to resolve this situation. And the filing deadline is in two weeks from now. So if you got hit back then, you can [check the details and file](https://11th.com/cases/aimmune-investor-settlement) for payment.
Anyways, did anyone here get damaged by $AIMT back then? How much were your losses if so?

Share